DAS28 and RAPID-3 results at 3, 6, and 12 months of treatment.
| DAS28 Score | 3 Mos | 6 Mos | 12 Mos | |||
|---|---|---|---|---|---|---|
| Active | Control | Active | Control | Active | Control | |
| DAS28 < 3.2 | 29/106 (27.4%) | 27/105 (25.7%) | 59/106 (55.7%) | 60/105 (57.1%) | 84/106 (79.2%) | 81/105 (77.1%) |
| DAS28 3.2–5.1 | 56/106 (52.8%) | 55/105 (52.4%) | 24/106 (22.6%) | 23/105 (21.9%) | 14/106 (13.2%) | 14/105 (13.3%) |
| DAS28 > 5.1 | 21/106 (19.8%) | 23/105 (21.9%) | 23/106 (21.7%) | 22/105 (20.9%) | 8/106 (7.5%) | 10/105 (9.5%) |
| RAPID-3, mean ± SD | 4.9 ± 0.3 | 5.1 ± 0.2 | 3.56 ± 0.2 | 3.58 ± 0.3 | 1.91 ± 0.3 | 1.89 ± 0.2 |
For the DAS28 score, chi-squared test was used. For the RAPID-3 score, Student t test was used. DAS28: 28-joint Disease Activity Score; RAPID-3: Routine Assessment of Patient Index Data 3.